FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W55952895> ?p ?o ?g. }

• W55952895 abstract "This study was carried out in health institutions in Ogun State to evaluate the rational use of artemisinin based combination therapies (ACTs) for the treatment of malaria. Data was collected using structured questionnaires. A total of 200 questionnaires were administered and returned. One hundred and eight (108) (54%) doctors and 92 (46%) pharmacists were interviewed. Eighty six (86) (79.6%) doctors and 82 (89.1%) pharmacists agreed that the ACTs were more effective than monotherapy for the treatment of malaria. Twenty (20) (18.5%) doctors still thought that monotherapy was more effective and 2 (1.9%) doctors were indifferent. Forty nine (49) (45.4%) doctors and 70 (76.1%) pharmacists use ACTs as first line antimalarial. Out of the 200 respondents, 173 (86.5%) were not aware that taking antioxidants such as vitamin C concurrently with the ACTs caused an inhibition of antimalarial effect. One hundred and sixty two (162) (81%) of total respondents took precautions while administering the ACTs and 38 (19%) took no precautions such as: “avoid alcohol and cigarettes” (83.5%), “take with fatty meals” (98.5%), “report any side effect immediately” (63.5%) and “don’t combine with any drug or herbal mixture for the first 24 hours” (12.5%). Ninety two (92) (85.2%) doctors and 72 (78.3%) pharmacists always order for a laboratory investigation before prescribing the ACTs. Twenty two (22) (20.4%) doctors and 12 (13.0%) pharmacists monitor patient’s compliance with medication by getting feedback from the patients. Fifty five (55) (53.9%) doctors and 82 (89.1%) pharmacists never documented adverse effect of ACTs experienced by the patients. ACTs were prescribed by 100% of the respondents in the second and third trimester of pregnancy because of their safety during these periods of pregnancy. Using statistical package for social sciences (SPSS), awareness that the ACTs taken with antioxidants such as ascorbic acid, antimalarial effect increases with practitioners’ years of practice. Most of the practitioners’ stocks of ACTs are from medical representatives, therefore pharmaceutical companies will play a pivotal role in providing these drug information in literatures distributed to the health practitioners with comprehensive information on the proper use of the ACTs. Keywords : pharmacists, doctors, artemisinin, malaria, rational use, combination therapy Nigerian Journal of Pharmaceutical Research , Vol. 8 No 1 pp. 84 - 91 (September 2010)" @default.
• W55952895 created "2016-06-24" @default.
• W55952895 creator A5020160925 @default.
• W55952895 creator A5020785827 @default.
• W55952895 date "2010-01-01" @default.
• W55952895 modified "2023-09-23" @default.
• W55952895 title "A Survey of the Rational use of Artemisinin Based Combination Therapies (ACTs) for the Treatment of Malaria among Health Practitioners in Ogun State, South West Nigeria" @default.
• W55952895 hasPublicationYear "2010" @default.
• W55952895 type Work @default.
• W55952895 sameAs 55952895 @default.
• W55952895 citedByCount "0" @default.
• W55952895 crossrefType "journal-article" @default.
• W55952895 hasAuthorship W55952895A5020160925 @default.
• W55952895 hasAuthorship W55952895A5020785827 @default.
• W55952895 hasConcept C104863432 @default.
• W55952895 hasConcept C17744445 @default.
• W55952895 hasConcept C203014093 @default.
• W55952895 hasConcept C2776120307 @default.
• W55952895 hasConcept C2778048844 @default.
• W55952895 hasConcept C2778371730 @default.
• W55952895 hasConcept C2778719706 @default.
• W55952895 hasConcept C3020757330 @default.
• W55952895 hasConcept C3116431 @default.
• W55952895 hasConcept C512399662 @default.
• W55952895 hasConcept C71924100 @default.
• W55952895 hasConceptScore W55952895C104863432 @default.
• W55952895 hasConceptScore W55952895C17744445 @default.
• W55952895 hasConceptScore W55952895C203014093 @default.
• W55952895 hasConceptScore W55952895C2776120307 @default.
• W55952895 hasConceptScore W55952895C2778048844 @default.
• W55952895 hasConceptScore W55952895C2778371730 @default.
• W55952895 hasConceptScore W55952895C2778719706 @default.
• W55952895 hasConceptScore W55952895C3020757330 @default.
• W55952895 hasConceptScore W55952895C3116431 @default.
• W55952895 hasConceptScore W55952895C512399662 @default.
• W55952895 hasConceptScore W55952895C71924100 @default.
• W55952895 hasIssue "1" @default.
• W55952895 hasLocation W559528951 @default.
• W55952895 hasOpenAccess W55952895 @default.
• W55952895 hasPrimaryLocation W559528951 @default.
• W55952895 hasRelatedWork W1588298614 @default.
• W55952895 hasRelatedWork W1791070141 @default.
• W55952895 hasRelatedWork W1832016659 @default.
• W55952895 hasRelatedWork W194513362 @default.
• W55952895 hasRelatedWork W2024662046 @default.
• W55952895 hasRelatedWork W2055204948 @default.
• W55952895 hasRelatedWork W2079013844 @default.
• W55952895 hasRelatedWork W2228129444 @default.
• W55952895 hasRelatedWork W2414896296 @default.
• W55952895 hasRelatedWork W2507199502 @default.
• W55952895 hasRelatedWork W2555424305 @default.
• W55952895 hasRelatedWork W2612771256 @default.
• W55952895 hasRelatedWork W2943463282 @default.
• W55952895 hasRelatedWork W3047787758 @default.
• W55952895 hasRelatedWork W3049111272 @default.
• W55952895 hasRelatedWork W3092256260 @default.
• W55952895 hasRelatedWork W52698778 @default.
• W55952895 hasRelatedWork W2181785449 @default.
• W55952895 hasRelatedWork W2187570769 @default.
• W55952895 hasRelatedWork W2275960755 @default.
• W55952895 hasVolume "8" @default.
• W55952895 isParatext "false" @default.
• W55952895 isRetracted "false" @default.
• W55952895 magId "55952895" @default.
• W55952895 workType "article" @default.